CASI Pharmaceuticals Inc Forecast, price target & analysts
CASI Pharmaceuticals Inc Target price 2024 - Analyst rating & recommendation
CASI Pharmaceuticals Inc Classifications & Recommendation:
CASI Pharmaceuticals Inc Price Target
| Target Price | $6.00 |
| Price | $4.29 |
| Potential |
39.86%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a CASI Pharmaceuticals Inc price target 2025.
The average CASI Pharmaceuticals Inc target price is $6.00.
This is
39.86%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend CASI Pharmaceuticals Inc to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CASI Pharmaceuticals Inc stock has an average upside potential 2025 of
39.86%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 33.88 | 19.80 |
| 41.57% | ||
| Net Margin | -79.89% | -102.22% |
| 27.94% |
1 Analyst has issued a sales forecast CASI Pharmaceuticals Inc 2024 . The average CASI Pharmaceuticals Inc sales estimate is
This results in the following potential growth metrics:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.02 | -1.51 |
| 25.25% | ||
| P/E | negative | |
| EV/Sales | 4.69 |
Based on analysts' sales estimates for 2024, the CASI Pharmaceuticals Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
CASI Pharmaceuticals Inc...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
